Clinical trial

Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic…

NCT00452660 · Wolfson Medical Center, Other · Completed

Key facts

NCT number NCT00452660
Title Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load
Official title A Phase IV , Multicenter ,Open Label ,Non Comparative ,Investigator Initiated Study , Evaluating the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load
Lead sponsor Wolfson Medical Center, Other
Collaborators Hadassah Medical Organization Tel-Aviv Sourasky Medical Center Sheba Medical Center Soroka University Medical Center
Status Completed
Phase Phase 4
Study type Interventional
Conditions Myelodysplastic Syndrome
Intervention type Drug
Interventions Exjade
Enrollment 21
Start date May 1, 2007
Primary completion Aug 1, 2008
Completion Aug 1, 2008
First posted Mar 27, 2007
Last update posted Jun 16, 2014
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies